Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Johnson & Johnson Company Info
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
News & Analysis
Want Decades of Passive Income? 2 Stocks to Buy Now.
There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing.
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
Johnson & Johnson's days of being a top healthcare stock could be long gone.
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
These are some of the best-performing stocks in what's arguably society's most important industry.
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2030?
Can Johnson & Johnson stock become a hot buy for growth-focused investors, or is this mainly just a dividend play?
Want $1,000 in Ultra-Safe Annual Dividend Income? Invest $19,000 Into the Following 3 Time-Tested Dividend Kings.
These rock-solid dividend stocks, which sport an average yield of 5.26%, have raised their base annual payouts for between 54 and 62 consecutive years.
Johnson & Johnson Stock Has 33% Upside, According to 1 Wall Street Analyst
Management's thesis regarding the spinoff is now being tested.
2 Beaten-Down Stocks to Buy and Hold for 10 Years
One is a longtime healthcare leader, the other a newcomer; both have bright futures despite recent obstacles.
Dividend Kings of 2024
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
Valuation
Podcast Episodes
An Investor's View of Johnson & Johnson's Talc Settlement
We also take a look at Chewy's growth initiatives.
Johnson & Johnson's Big Purchase, Amazon's New Moves, and More
Plus, we run through some shortcuts that could help you with your financial planning.
Times Like These Are Why You Want to Own a Business Like This
Plus, a look at the 4% rule and a common misconception about retirement spending.
Making Sense of Financial Advice on TikTok
Plus a look at what to like about Johnson & Johnson.
Earnings Transcripts
Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript
JNJ earnings call for the period ending December 31, 2023.
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
JNJ earnings call for the period ending September 30, 2023.
Johnson & Johnson (JNJ) Q2 2023 Earnings Call Transcript
JNJ earnings call for the period ending June 30, 2023.
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
JNJ earnings call for the period ending December 31, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.